Background: Recent innovations in biomaterials technology have led to the development of innovative sorbents adopted as adsorbing devices in the field of extracorporeal blood purification therapies. As removal mechanism, adsorption allows to remove specific molecules, selectively binding them to sorbent materials. In addition to the material properties, a quintessential aspect influencing device properties is blood flow distribution within the sorbent particles. Objectives: In order to adequately characterize the potential adsorbing properties for an effective blood purification therapy, an in vitro study assessing the fluid dynamics inside 3 new cartridges, HA130, HA230 and HA330 (Jafron, Zhuhai City, -China) was conducted through CT imaging technique. -Methods: The cartridges were placed in vertical position in the CT -gantry. Dye solution was circulated through the cartridges at 250 mL/min, longitudinal sections, 0.5 cm thick, were recorded for 60 s. Furthermore, an in vitro test was conducted to build pressure drop profiles. Blood was circulated at a different flow rate, 100–400 mL/min, step 50 mL/min. Pre and post cartridges pressures were acquired and pressure drop calculated. Results: Sequential images demonstrated an excellent distribution of the flow inside the cartridges. Average flow velocity was 0.37 cm/s for the 3 cartridges. HA130 had a homogeneous flow profile along the entire length of the device; HA230 and HA330 showed minimal differences between central and peripheral regions. Pressure drop profiles resulted linear, increasing proportionally with blood flow rate and packing density. Conclusions: We may conclude that the structural and functional design of the studied cartridges is adequate for haemoperfusion with no channelling phenomena. This ensures maximum and optimal utilization of the sorbent contained in the devices.

1.
Husain-Syed F, Ricci Z, Brodie D, Vincent JL, Ranieri VM, Slutsky AS, et al. Extracorporeal organ support (ECOS) in critical illness and acute kidney injury: from native to artificial organ crosstalk.
Intensive Care Med
. 2018 Sep;44(9):1447–59.
2.
Ricci Z, Romagnoli S, Ronco C, La Manna G. From continuous renal replacement therapies to multiple organ support therapy.
Contrib Nephrol
. 2018;194:155–69.
3.
Clark WR, Gao D, Neri M, Ronco C. Solute transport in hemodialysis: advances and limitations of current membrane technology.
Contrib Nephrol
. 2017;191:84–99.
4.
Cerdá J, Villa G, Neri M, Ronco C. Technology in medicine: moving towards precision management of acute kidney injury.
Contrib Nephrol
. 2018;193:89–99.
5.
Clark WR, Gao D, Lorenzin A, Ronco C. Membranes and Sorbents.
Contrib Nephrol
. 2018;194:70–9.
6.
Clark WR, Ferrari F, La Manna G, Ronco C. Extracorporeal sorbent technologies: basic concepts and clinical application.
Contrib Nephrol
. 2017;190:43–57.
7.
Ankawi G, Neri M, Zhang J, Breglia A, Ricci Z, Ronco C. Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls.
Crit Care
. 2018 Oct;22(1):262.
8.
Ronco C, Ghezzi PM, Morris A, Rosales L, Wang E, Zhu F, et al. Blood flow distribution in sorbent beds: analysis of a new sorbent device for hemoperfusion.
Int J Artif Organs
. 2000 Feb;23(2):125–30.
9.
Polaschegg HD, Ronco C, Soli M. Characterization of flow-dynamic pattern in a new sorbent cartridge for combined hemoperfusion-hemodialysis.
Contrib Nephrol
. 2001;133:154–65.
10.
Ronco C, Ghezzi PM, Metry G, Spittle M, Brendolan A, Rodighiero M, et al. Effects of hematocrit and blood flow distribution on solute clearance in hollow-fiber hemodialyzers.
Nephron
. 2001 Nov;89(3):243–50.
11.
Kim JC, Kim JH, Sung J, Kim HC, Kang E, Lee SH, et al. Effects of arterial port design on blood flow distribution in hemodialyzers.
Blood Purif
. 2009;28(3):260–7.
12.
Ankawi G, Fan W, Pomarè Montin D, Lorenzin A, Neri M, Caprara C, et al. A new series of sorbent devices for multiple clinical purposes: current evidence and future directions.
Blood Purif
. 2019;47:94–100 .
13.
Pomarè Montin D, Ankawi G, Lorenzin A, Neri M, Caprara C, Ronco C. Biocompatibility and cytotoxic evaluation of new sorbent cartridges for blood hemoperfusion.
Blood Purif
. 2018;46(3):187–95.
14.
Li WH, Yin YM, Chen H, Wang XD, Yun H, Li H, et al. Curative effect of neutral macroporous resin hemoperfusion on treating hemodialysis patients with refractory uremic pruritus.
Medicine
2017;96:e6160.
15.
Dong H, Weng YB, Zhen GS, Li FJ, Jin AC, Liu J. Clinical emergency treatment of 68 critical patients with severe organophosphorus poisoning and prognosis analysis after rescue.
Medicine (Baltimore)
. 2017 Jun;96(25):e7237.
16.
Huang Z, Wang SR, Su W, Liu JY. Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column.
Ther Apher Dial
. 2010 Dec;14(6):596–602.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.